Amy Hernandez, PA
Payments from drug & device makers
Across 58 payments — averaging $21.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$250
- AbbVie$216
- Tersera Therapeutics LLC$80
- Gilead$73
- Melinta Therapeutics, LLC$72
- Merck$51
- plus $513 from 17 others
What the payments were for
- Food & beverage$1,23899%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 12 | $250 |
| AbbVie | 10 | $216 |
| Tersera Therapeutics LLC | 3 | $80 |
| Gilead | 3 | $73 |
| Melinta Therapeutics, LLC | 3 | $72 |
| Merck | 3 | $51 |
| Nestle Healthcare Nutrition Inc. | 3 | $50 |
| Smith+Nephew | 1 | $41 |
| Shionogi Inc | 2 | $41 |
| Insmed, Inc. | 2 | $39 |
| Octapharma USA, Inc. | 2 | $38 |
| Viiv Healthcare Company | 1 | $38 |
| Organon | 1 | $33 |
| Pfizer | 2 | $31 |
| Theratechnologies Inc. | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| UCB, Inc. | 1 | $21 |
| Sandoz | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Bristol Myers Squibb | 1 | $15 |
How this compares
$1,254 in reported general payments places this provider in the 75th percentile of 364 medical providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methenamine Hippurate | 47 | $3,964 |
| Vancomycin Hcl | 26 | $3,677 |
| Cephalexin | 98 | $3,653 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $2,286 |
| Fluconazole | 42 | $1,602 |
| Doxycycline Hyclate | 41 | $1,360 |
| Clindamycin Hcl | 23 | $1,321 |
| Penicillin V Potassium | 41 | $1,113 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 30 | $590 |
| Clotrimazole | 19 | $345 |
| Ciprofloxacin Hcl | 21 | $283 |
| Amoxicillin | 14 | $210 |
Paid to pharmacies, not to this prescriber.
Other medical in Salem
- Benjamin WillettSalem$11K
- Jeffrey RennaSalem$9K
- Brolin JohnsonSalem$6K
- Elizabeth SchmidtSalem$6K
- Kurt AtkinSalem$5K
- Jonathan KiserSalem$4K
- Ryan HermansenSalem$4K
- Sarah DyckmanSalem$3K
- Nicholas WilliamsSalem$3K
- Kenneth LowrySalem$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.